• Introduction
  • Why Almac?
  • People
  • Facilities
• Biomarker Discovery and Validation
  • Companion Diagnostics
  • Pharmacodynamic Biomarkers
  • Prognostic tests
  • Drug Repositioning
  • Consultancy
• Bioinformatics Solutions
  • Our Approach
  • Solutions
  • People and Experience
  • Tools and Innovation
• Genomic services
  • Gene Expression and SNP analysis
  • qPCR and cell line modelling
  • Bioinformatics
• Proprietary Discovery Arrays
  • Unique Content
  • Work with FFPE and fresh frozen tissue
  • Discover Targets, signatures and answers
• Resources
  • Technical Documentation
  • Posters and presentations
  • Publications

Discover Targets, signatures and answers

Almac’s proprietary discovery arrays have been developed to provide the optimal platform for biomarker discovery and development across multiple disease areas (Xcel™ array) and specific disease areas (DSA®).

Almac provides access to these platforms to its partners in Pharma, Biotech and Academia as part of its biomarker partnering solutions.

These innovative tools are an important asset to Almac’s drive to enable personalised medicine.